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Abstract Protein kinase CK2 is composed of two regulatory
L-subunits and two catalytic K- or KP-subunits. To analyse these
subunits individually we generated antibodies against unique
peptides derived from the K-, KP- and L-subunit. Immunofluo-
rescence studies with these antibodies revealed the presence of all
three CK2 subunits in the cytoplasm and weakly in the nucleus
with strong signals around the nuclear membrane. Double
staining experiments revealed a co-localisation of all three
subunits with tubulin. A direct association between the CK2
K- and the KP-subunit and tubulin was confirmed by co-
immunoprecipitation experiments as well as by Far Western
analysis. There was no binding of the CK2 L-subunit to tubulin.
Thus, with tubulin we have identified a new binding partner
specific for the catalytic subunits of CK2.
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1. Introduction
Protein kinase CK2 is a ubiquitously expressed protein ki-
nase which is composed of two catalytic KP- or K-subunits and
two regulatory L-subunits [1,2].
This enzyme catalyses the phosphorylation of a great num-
ber of substrates which are implicated in transcription, signal
transduction processes, growth regulation, various steps of
development and in the formation of cellular shape and ar-
chitecture [2]. Substrates of CK2 include cytoskeletal proteins
such as myosin heavy and light chains [2], troponin-T, L-tu-
bulin, tau protein [3], Mab-1B protein [4] and dynein [5].
Substrates of CK2 are localised in the cytosol, in the nucleus
and under certain circumstances also at the nucleosomes, at
the centrosomes [6], to the spindle apparatus in dividing cells
[7], at the nuclear matrix [8,9] and in the nucleoli [10]. Phos-
phorylation of these proteins a¡ects their assembly and dy-
namics. CK2 is not only implicated in the expression of a
distinct cell type but also in di¡erentiation and movement of
cells. CK2 itself has been found to be present in the nucleus,
cytosol, in microsomal and mitochondrial fractions [11,12]
and in the extracellular matrix [13]. In addition to the inter-
action between an enzyme and a substrate there are accumu-
lating data that CK2 as a holoenzyme or that the individual
subunits of CK2 bind to a number of cellular and viral pro-
teins (for review see: [1]). Among these proteins is the growth
suppressor p53 which binds to the CK2 L-subunit [14,15] and
the p21WAF1 protein, which is transactivated by p53 [16]. In
both cases binding of these proteins to CK2 leads to a reduc-
tion in the activity of CK2 [16,17] indicating that these two
proteins are negative regulators of the activity of CK2. The
nucleolar protein NOPP140 also binds to the L-subunit of
CK2 and it is suggested that this interaction may be impli-
cated in the cytoplasmic/nuclear transport of the L-subunit
[18]. In addition also mos and the A-raf kinase, proteins
which are involved in signal transduction bind to the L-sub-
unit of CK2 [19,20]. Also binding partners for the K-subunit
of CK2 such as nucleolin [10] and PP2a [21] are known where-
as only little is known about proteins binding to the KP-sub-
unit of CK2.
Studies on the subcellular localisation were mainly per-
formed with antibodies raised against the CK2 holoenzyme
or against the K- or L-subunit. Although the K- and the
KP-subunits are highly homologous to each other each subunit
is encoded by a separate gene [22] and there are unique re-
gions on the polypeptide chains of CK2K and KP. There is
ample evidence that di¡erent tissue types may express the K-
and the L-subunits at varying levels (for review see: [23])
whereas little is known about the expression of the KP-subunit.
We now have generated antibodies against individual peptides
of the CK2 K-, KP- or L-subunit. With these antibodies we
localised all three subunits in mouse embryo ¢broblasts in
the cytosol and in the nucleus with an accumulation around
the nuclear membrane. It turned out that this immunostaining
was very similar to the staining that was observed for tubulin.
Co-immunoprecipitation studies and in vitro binding studies
revealed that the K- and KP-subunit bound to tubulin whereas
there is no direct binding of tubulin to the regulatory L-sub-
unit of CK2.
2. Materials and methods
2.1. Cell culture
Mouse embryo ¢broblasts (MEF1229) [24] and RKO cells [25] were
maintained in Dulbecco’s modi¢ed Eagle’s medium (DMEM) supple-
mented with 10% foetal calf serum (FCS). Cells were grown to 75%
subcon£uence in 10 cm dishes in a 5% CO2 atmosphere.
2.2. Preparation of cell extracts
Cells were harvested, washed 3U with phosphate bu¡ered saline
(PBS), pH 7.4 and resuspended in lysis bu¡er (100 mM Tris-HCl,
pH 9.0, 100 mM NaCl, 0.5% (v/v) NP40, 1% Trasylol). Proteins
were extracted for 1 h on ice. Cell debris were eliminated by centri-
fugation (4‡C, 30 min, 13 000Ug).
2.3. Immuno£uorescence
Cells were grown on coverslips until they were 50^70% con£uent.
Cells were ¢xed in 2% formaldehyde in PBS, pH 7.4, for 15 min at
20‡C and then washed with PBS, pH 7.4, for 3U10 min. Cells were
permeabilised with 0.2% Triton X-100 containing 1% normal goat
serum (NGS) in PBS for 5 min on ice. Cells were washed again
with PBS containing 1% NGS 3 times for 10 min and then incubated
with a primary antibody in the appropriate concentration for 1 h at
0014-5793 / 99 / $20.00 ß 1999 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 9 ) 0 1 4 9 2 - 1
*Corresponding author. Fax: (49) (6841) 166027.
E-mail: tm13mm@rz.uni-sb.de
FEBS 22925 18-11-99 Cyaan Magenta Geel Zwart
FEBS 22925 FEBS Letters 462 (1999) 51^56
room temperature in a humidi¢ed chamber. Cells were washed under
the same conditions. Cells were incubated with the secondary anti-
body (FITC or TRITC conjugated) at room temperature for 1 h in a
dark, humidi¢ed chamber. Finally, cells were washed again with PBS
(4U10 min). The coverslips were ¢xed with a drop of mounting media
and analysed under a £uorescence microscope.
2.4. Far Western blot analysis
Proteins dissolved in sodium dodecyl sulfate (SDS) bu¡er (130 mM
Tris-HCl, pH 6.8, 0.02% bromophenol blue (w/v), 10% 2-mercapto-
ethanol, 20% glycerol (v/v), 4% SDS were separated in a SDS-poly-
acrylamide gel, renatured in 10U PBS for 2 h on ice, then the refolded
proteins were transferred onto a PVDF Western blotting membrane
(Boehringer Mannheim) in a bu¡er containing 20 mM Tris-HCl,
150 mM glycine, pH 8.9. The membrane was blocked for 1 h in
binding bu¡er (0.05% (v/v) Tween 20 in PBS, pH 7.4) with 5% dry
milk. The probe (tubulin) with a ¢nal concentration of 1 Wg/Wl was
diluted in binding bu¡er with 1% dry milk and incubated for 1 h at
4‡C. The membrane was washed in PBS and incubated for 1 h with an
antibody against the probe which was dissolved in binding bu¡er with
1% dry milk in a dilution of 1:1000. The blot membrane washed in
binding bu¡er was decorated with the secondary antibody and as-
sayed with the ECL system (Amersham, Braunschweig, Germany)
according to the manufacturer’s instructions.
2.5. Immunoprecipitation
For immunoprecipitation we use polyclonal sera (serum #26, #30,
#32) raised against C-terminal peptides from protein kinase CK2 K-
(CTPSPLGPLAGSP), CK2 KP- (CEQSQPCADNAVLSSGLTAAR)
or CK2 L-subunit (CSNFKSPVKTIR), respectively, and monoclonal
anti-K-tubulin antibodies (Sigma). A protein A/G-sepharose mixture
was preincubated for 1 h with 50 Wl of the di¡erent sera or with 10 Wl
(1 Wg/Wl) of the monoclonal anti-K-tubulin antibody and washed three
times with PBS, pH 7.4. One miligram cell extract or alternatively
10 Wg puri¢ed proteins were preincubated with a mixture of protein
A- and protein G-sepharose (Pharmacia) to remove unspeci¢c binding
proteins. The supernatant was applied to the preincubated sepharose-
antibody-matrix and incubated for 1 h. The supernatant was removed
and the antibody-matrix washed three times with NET bu¡er with
0.5% (v/v) NP40. The immune complex was subjected to SDS-poly-
acrylamide gel electrophoresis, followed by Western blotting.
2.6. Puri¢cation of CK2 holoenzyme
Recombinant CK2 holoenzyme cloned in a bicistronic vector [26]
was expressed in Escherichia coli BL21 (DE3) and the holoenzyme
was puri¢ed according to a protocol published by [27]. The bacterial
pellet was lysed and after incubation on ice for 10 min, the lysate was
sonicated two times and centrifuged (10 000Ug, step 1). The pellet
was resuspended in bu¡er P1500 (20 mM Tris-HCl, pH 8.0, 7 mM
2-mercaptoethanol, 1 mM phenylmethyl sulfonylchloride (PMSF) and
1.5 M NaCl). Proteins were extracted overnight, pooled with the
supernatant from the ¢rst step, and dialysed against bu¡er P300
(20 mM Tris-HCl, pH 8.0, 7 mM 2-mercaptoethanol, 1 mM PMSF
and 300 mM NaCl). The lysate was loaded onto a P11 column pre-
equilibrated with bu¡er P300 and eluted with a linear gradient from
0.3^1.5 M NaCl. Fractions containing active holoenzyme were dia-
lysed against bu¡er P300, concentrated and loaded onto a Superose-6
column (Pharmacia). After gel ¢ltration the peak fractions were col-
lected.
2.7. Expression and puri¢cation of bacterially expressed proteins
The three di¡erent subunits (K, KP and L in pGS) of the protein
kinase CK2 were transformed into E. coli strain BL21 (DE3). Clones
were incubated overnight in 50 ml LB-medium. One liter LB-medium
was inoculated with the overnight-culture, grown to early log phase
and induced with 1 mM isopropyl-L-D-thiogalactoside (IPTG) at 30‡C
for 6 h. Cells were harvested by centrifugation and resuspended in 6 M
guanidine hydrochloride, 0.1 M sodium phosphate, pH 8.0 and lysed
at 4‡C overnight. The lysate was cleared by centrifugation and loaded
onto a prewashed Ni2-chelate agarose column and incubated for 1 h
at room temperature. The column was washed with 10 volumes of
lysis bu¡er, followed by 10 volumes of lysis bu¡er pH 6.0, and lysis
bu¡er pH 8.0 containing 20 mM imidazole. Proteins were eluted with
lysis bu¡er containing 300 mM imidazole and subsequently dialysed
overnight against dialysis bu¡er A (20 mM Tris-HCl, pH 7.5, 100 mM
KCl, 5 mM MgCl2, 0.1% Tween 20).
3. Results
In order to analyse the individual subunits of CK2 we gen-
erated a rabbit serum against a peptide of 13 amino acids
derived from the unique region of the K-subunit from amino
acid 360 to 371 (serum #26) (Fig. 1A). An other antibody
(serum #30), which was also raised in rabbits, is directed
against a peptide of 21 amino acids corresponding to the
unique sequence of the KP-subunit from amino acid 330 to
349 (Fig. 1A). Rabbit serum #32 was raised against a peptide
corresponding to the 10 last amino acids of the L-subunit
(Fig. 1A). In order to test the speci¢city of the newly gener-
ated antibodies individual subunits of CK2 were expressed in
bacteria and the proteins separated on an SDS polyacrylamide
gel followed by a transfer onto a PVDF membrane. The mem-
brane with the K-subunit was either incubated with serum #26
or as a control with monoclonal antibody 1AD9 [28] directed
against a common region of the K- and KP-subunit. The mem-
brane containing the KP-subunit was either incubated with
serum #30 or with monoclonal antibody 1AD9. The third
membrane containing the L-subunit of CK2 was incubated
either with serum #32 or with monoclonal antibody 6D5
[29] as a control. Fig. 1B shows that all three sera reacted
with the corresponding subunits comparable to the monoclo-
nal antibodies used as controls. There was no cross-reactivity
of the antibody against the KP-subunit with the K-subunit or
vice versa (data not shown).
Next, we wanted to know whether the newly generated anti-
bodies would react with the proteins in a cell extract and
whether they would also precipitate the CK2 holoenzyme.
Cell extracts from RKO cells [25] were incubated with either
serum #26, serum #30 or serum #32. Immunoprecipitates
were analysed on an SDS polyacrylamide gel followed by a
Western blot analysis using a mixture of monoclonal antibod-
ies 1AD9 and 6D5. Fig. 1C shows that all three sera immu-
noprecipitated the CK2 holoenzyme, although the amount of
the K- or the KP-subunit in the immunoprecipitates with serum
#26 or serum #30 varied. In the serum #26 immunoprecipi-
tate the KP-subunit is hardly detectable (lane 2) whereas in the
serum #30 immunoprecipitate there is a great excess of
KP-subunit compared to the K-subunit. Thus, we have shown
that the newly generated antibodies react with the individual
subunits and moreover they immunoprecipitate the CK2 holo-
enzyme from a mammalian cell extract. To study the sub-
cellular distribution of individual subunits of CK2 we used
primary mouse embryo ¢broblasts in order to avoid any cel-
lular in£uences by cell transformation, viruses or other fac-
tors. Cells were grown to subcon£uence, ¢xed and incubated
with the sera against the individual subunits of CK2, followed
by a rhodamine labelled goat anti-rabbit serum. As shown in
Fig. 2A^C all three subunits of CK2 were localised in the
cytoplasm and in the nucleus with an accumulation around
the nuclear membrane. This subcellular distribution resembled
the subcellular localisation described for tubulin [30]. There-
fore, we performed a double labelling experiment. Cells were
incubated with serum #26 directed against the K-subunit of
CK2 followed by a TRITC labelled goat anti-rabbit serum.
Then, cells were incubated with a mouse anti-K-tubulin anti-
serum followed by an FITC labelled goat anti-mouse serum.
As shown in Fig. 2D,E both proteins co-localised in the cell
around the nuclear membrane. A very similar co-localisation
was shown for the KP- and for the L-subunit of CK2 (data not
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shown). A control experiment with an antibody against actin
gave a di¡erent staining pattern for the CK2 subunits and for
actin indicating that the CK2 subunits were not co-localised
with actin (data not shown).
Having shown the co-localisation of the CK2 subunits with
K-tubulin by immuno£uorescence we next asked whether we
could show an association of these proteins with biochemical
methods. Therefore, we tried to co-immunoprecipitate CK2
complexes with tubulin from eukaryotic cell extracts. Mouse
embryo ¢broblasts were extracted and the cell extract incu-
bated with serum against the K-, KP- or the L-subunit of CK2.
Immunoprecipitates were analysed on a SDS polyacrylamide
gel followed by Western blot analysis using an antibody di-
rected against K-tubulin. The Western blot result is shown in
Fig. 3A. K-Tubulin is co-immunoprecipitated with antibodies
against all three subunits of CK2. This result is not unex-
pected since eukaryotic cells harbour tetrameric complexes
composed of KP2/L2,K2/L2 and KKP/L2 subunits. As shown in
Fig. 1Cby using an antibody against the K-, KP- or the
L-subunit we will immunoprecipitate the di¡erent isoforms
of the holoenzyme. Thus, it remains possible that tubulin
binds to all three subunits or only to one or two of them.
In order to study which of the subunits of CK2 might
interact with tubulin directly we separated either CK2 KP or
Fig. 1. Characterisation of newly-generated sera against CK2 K- (serum #26), KP- (serum #30) and L-subunit (serum #32). A: Location of se-
lected epitopes on the polypeptide chain of CK2 subunits. B: Western blot analysis of puri¢ed recombinant subunits of CK2 with serum #26
(lane 2), #30 (lane 4) and #32 (lane 6). As a control the membrane was decorated with established monoclonal antibodies 1AD9 against the K-
and KP-subunit (lanes 1 and 5) and 6D5 against the L-subunit (lane 3). C: Immunoprecipitation experiment with serum #26 (lane 2), #30 (lane
4) and #32 (lane 6). CK2 subunits were precipitated from 1 mg cell extract. Immunoprecipitates were separated by SDS-polyacrylamide gel
electrophoresis and transferred onto a PVDF-membrane. CK2 was detected with a mixture of monoclonal antibodies 1AD9 and 6D5. C: con-
trol precipitate without antibody.
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the CK K/L holoenzyme expressed from a bicistronic vector
[26] through an SDS polyacrylamide gel. After gel electropho-
resis and renaturation proteins were transferred onto a PVDF
membrane and the membrane was incubated with commer-
cially available tubulin, followed by an anti-K-tubulin anti-
body. Binding was detected by the ECL method. As shown
in Fig. 3B (lane 1), K-tubulin binds to the CK2 KP-subunit as
well as to the CK2 K-subunit (lane 2). As a control, we loaded
the CK2 KP (lane 3) and the CK2 K/L holoenzyme (lane 4) on
a SDS polyacrylamide gel and after transfer the proteins were
detected with a mixture of serum #26, serum #30 and serum
#32. These experiments demonstrated that the sample in lanes
2 and 4 contained the K and L-subunit of CK2. Since tubulin
reacted only with the K- and the KP-subunit we have to con-
clude that there is no binding of tubulin to the L-subunit of
CK2.
Next, we expressed individual subunits of CK2 in bacteria
and the bacterial cell extract was incubated with tubulin. CK2
K, KP or L were immunoprecipitated from the bacterial extract
with serum #26 speci¢c for the K-subunit, serum #30 which is
speci¢c for the KP-subunit or with serum #32 which is speci¢c
for the L-subunit. Immunoprecipitates were analysed on a
SDS polyacrylamide gel followed by Western blotting with
an antibody speci¢c for K-tubulin. As shown in Fig. 3C K-
tubulin was co-immunoprecipitated with the K- and the KP-
subunit which is in agreement with the results shown in the
Far Western analysis. There was no co-immunoprecipitation
of K-tubulin with the L-subunit of CK2 which con¢rms the
result obtained with the Western blot experiments shown in
Fig. 3B.
4. Discussion
Using antibodies against the CK2 holoenzyme or the K- or
L-subunit it was demonstrated that CK2 is localised either in
the cytoplasm or in the nucleus [6,7,31^34]. Due to the ex-
tended homology between the K- and the KP-subunit in these
early studies it was impossible to discriminate between the K-
and the KP-subunit. Therefore, in the present study, we gen-
erated antibodies against peptides derived from the unique
region of the K- as well as from the unique region of the
KP-subunit. Antibodies against similar peptides of the individ-
ual subunits [35,36] were used to detect di¡erent isoforms of
CK2 consisting of K2L2, KKPL2 and K2L2 in mammalian cells,
which were shown to assemble with di¡erent kinetics [35].
Recently, these antibodies were used for microinjection experi-
ments where it was shown that they interfere severely with
proliferation stimulation of cells [36]. It was reported earlier
that antibodies against the holoenzyme did not react with the
L-subunit [31] which means that any information about the L-
subunit is questionable in studies where antibodies against the
holoenzyme were used. By using our newly generated anti-
bodies we show that they immunoprecipitate the individual
subunits of CK2 as well as the CK2 holoenzyme. Further-
more, it was already shown that our antibody directed against
the L-subunit not only precipitated the holoenzyme but also
that this immunopuri¢ed holoenzyme still has an e⁄cient ki-
nase activity [17]. In immuno£uorescence studies these anti-
bodies stained primary mouse embryo ¢broblasts in the
nucleus and in the cytoplasm with a strong accumulation
around the nuclear membrane. Staining of the nucleus is
Fig. 2. Indirect immuno£uorescence for the detection of individual subunits of CK2. Cells were grown on coverslips, ¢xed with 2% formalde-
hyde and permeabilised with 0.2% Triton X-100. The rabbit sera against the subunits of CK2 were used in a dilution of 1:50, the mouse mono-
clonal anti-K-tubulin antibody was diluted 1:1000. As secondary antibodies we used either TRITC conjugated goat anti-rabbit or FITC-conju-
gated goat anti-mouse-antibodies. A: serum #26, B: serum #30, C: serum #32, Double £uorescence: D: serum #26, E: anti-K-tubulin
antibody.
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weak for all three antibodies. A predominant localisation of
CK2 in the nucleus was found by Krek et al. [6] whereas
others found CK2 mainly in the cytosol [7]. However, in these
studies di¡erent antibodies against the CK2 holoenzyme or
polyclonal sera against individual subunits were used and it
may well be that under various cellular conditions incomplete
epitope recognition by these antibodies may explain the di¡er-
ent subcellular localisation. Moreover, the K- and the KP-sub-
unit interact with itself, with the L-subunit and with an in-
creasing number of cellular and viral proteins and these
protein-protein interactions may also prevent epitope recogni-
tion. We generated antibodies against regions on the polypep-
tide chain which to our current knowledge are not implicated
in protein-protein interactions. In addition di¡erent cell types
such as primary skin ¢broblasts, immortalised 3T3 cells and
tumour cells were used for the subcellular localisation of CK2.
It is possible that the subcellular localisation of CK2 may vary
with the phenotype of the cells. Moreover, there is some in-
dication that the subcellular localisation may vary with the
cell cycle [31,33]. Our present results using primary mouse
embryo ¢broblasts are similar to the results previously ob-
tained for the K-subunit of CK2 in mouse 3T3 cells [31].
The staining for CK2 observed in 3T3 cells as well as in the
primary mouse embryo ¢broblasts used in our present study
resembled the staining which was reported for K-tubulin [30]
and shown also in the present study using a commercially
available antibody against K-tubulin. Tubulin is not only co-
localised with the three subunits of CK2 but can also be co-
immunoprecipitated from mammalian cells with the antibod-
ies directed against the K-, KP- and the L-subunit. Co-immu-
noprecipitation experiments with individual subunits and K-
tubulin as well as Western blot experiments revealed that only
the K- and the KP- but not the L-subunit bind to K-tubulin.
It is known for a long time that protein kinase CK2 phos-
phorylates L-tubulin in vitro and in vivo [37^39]. Moreover
CK2 was also found to be associated with microtubules [40].
According to our present result CK2 may be involved in cy-
toskeletal reorganisation not only by phosphorylation of pro-
teins such as tubulin and myosin but also by stable associa-
tion with at least tubulin. CK2 forms stable complexes with
cellular and viral proteins [1,16,41,42] and these interactions
can alter the activity of the kinase itself [17,43] as well as of its
binding partners such as p53, PP2A and topoisomerase
[21,44^46]. One can also suppose a stable binding between
CK2 and microtubules that localise the kinase very closely
to its cytoskeletal substrates so that they can be phosphoryl-
ated more e⁄ciently. The cytoskeleton plays an important
role in the maintenance of cell shape and polarity and also
in cell mobility. There are some reports suggesting a role of
CK2 in cell polarity and di¡erentiation. The gene for the
catalytic subunit of CK2 in Schizosaccharomyces pombe was
found as a temperature sensitive recessive lethal mutation
(orb5), which confers a spherical morphology to the ¢lamen-
tous yeast [47]. Deletion of the gene for the regulatory L-sub-
unit of CK2 in S. pombe is not lethal, but shows also an
abnormal rounded morphology reminiscent of orb5 [48]. Fur-
thermore, the temperature sensitive mutation (cka1ts) of CK2
in Saccharomyces cerevisiae shows after shift to the restrictive
temperature a population of budded and unbudded cells with
a spherical morphology [49]. Also in neuroblastoma cells,
where the activity of CK2 was deleted through antisense tech-
nology, neuritogenesis and cell polarity were inhibited [50].
Thus, these studies reveal a role for CK2 in cell polarity
and di¡erentiation. Binding of CK2 to proteins such as tubu-
lin may target CK2 to substrates which are implicated in these
processes.
Fig. 3. Binding of CK2 K and KP to K-tubulin. A: Co-immunopreci-
pitation of CK2 K and KP with K-tubulin from mouse embryo ¢bro-
blasts. A protein A/G-sepharose mixture was preincubated with 50 Wl
of the sera (#26, #30 or #32) against the K-, KP- or L-subunit of
CK2. One miligram cell extract of mouse embryo ¢broblasts was
preincubated with a mixture of protein A/G sepharose. The super-
natant was applied to the preincubated sepharose-antibody-matrix.
After 1 h the supernatant was removed and the matrix was washed.
The immunoprecipitates were separated through an SDS polyacryl-
amide gel, transferred onto a PVDF-membrane, decorated with
anti-K-tubulin antibody and detected by the ECL method. Antibody
control (1 Wl serum #26 (lane 1), #30 (lane 2), #32 (lane 3)). Lane
4: sepharose preincubated with cell extract. Immunoprecipitate with
serum #26 (lane 5), #30 (lane 6), #32 (lane 7). B: Far Western blot
with CK2 K-, KP- and L-subunit and tubulin. Equal amounts of
CK2 KP (lane 1) or CK2 K/L holoenzyme (lane 2) were separated
through SDS polyacrylamide gels, renaturated and transferred onto
a PVDF-membrane. The membrane from one of these gels was in-
cubated with tubulin (1 Wg/Wl), followed by anti-K-tubulin antibody
(Sigma) and then detected by the ECL system (Amersham) and the
membrane from a second gel was incubated with a mixture of se-
rum #26, #30 and #32. Proteins were visualised by the ECL system
(lanes 3 and 4). C: Co-immunoprecipitation of puri¢ed CK2 K and
KP and tubulin. A protein A/G sepharose mixture was preincubated
with 50 Wl of serum #26, #30 or #32, respectively. The antibody-
sepharose-matrix was washed and incubated with 10 Wg tubulin and
equal amounts of puri¢ed CK2 K-, KP- and L-subunit (lanes 1, 4
and 7). As a control the protein A/G sepharose mixture without se-
rum was incubated with 10 Wg tubulin and equal amounts of puri-
¢ed CK2 K-, KP- and L-subunit (lanes 2, 5 and 8). As a further con-
trol a protein A/G sepharose mixture was preincubated with 50 Wl
of serum #26, #30 or #32 against the K-, KP- and L-subunit of
CK2, respectively, washed and incubated with 10 Wg of tubulin
(lanes 3, 6 and 9). After 1 h the supernatants were removed and the
matrix was washed. Immunoprecipitates were separated through an
SDS polyacrylamide gel, transferred onto a PVDF-membrane and
decorated with anti-K-tubulin antibody and detected by the ECL
method.
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